Trump lists India, Pakistan, Myanmar, 20 others as major drug transit countries
Trump specifically designated Afghanistan, Bolivia, Myanmar, Colombia and Venezuela as having "failed demonstrably" to meet international counternarcotics obligations.
US President Donald Trump has named 23 countries, including India, Pakistan and Myanmar, as major drug transit or major illicit drug producing countries.
Other listed countries include Afghanistan, The Bahamas, Belize, Bolivia, the People's Republic of China, Colombia, Costa Rica, the Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Laos, Mexico, Nicaragua, Panama, Peru, and Venezuela.
The countries were named in the 'Presidential Determination on Major Drug Transit or Major Illicit Drug Producing Countries for Fiscal Year 2026' submitted to the United States Congress on 15 September, according to a media note issued by the Department of State.
Keep updated, follow The Business Standard's Google news channel
The Department of State clarified that a country's presence on the foregoing list is not necessarily a reflection of its government's counterdrug efforts or level of cooperation with the US.
"The reason countries are placed on the list is the combination of geographic, commercial, and economic factors that allow drugs or precursor chemicals to be transited or produced, even if a government has engaged in robust and diligent narcotics control and law enforcement measures," reads the media note.
Trump specifically designated Afghanistan, Bolivia, Myanmar, Colombia and Venezuela as having "failed demonstrably" to meet international counternarcotics obligations during the previous 12 months.
Trump also urged Chinese leadership to take stronger sustained action against synthetic narcotics flows including nitazenes and methamphetamine, and to prosecute related drug criminals.
The Department of State noted that transnational organised crime's trafficking of fentanyl and other illicit drugs has created a national emergency in the US, remaining the leading cause of death for Americans aged 18-44.
